Neurocrine Biosciences, Inc. (NBIX)
131.15
+0.19
(+0.15%)
USD |
NASDAQ |
Feb 25, 16:00
131.14
0.00 (0.00%)
Pre-Market: 20:00
Neurocrine Biosciences Shareholders Equity (Annual) : 3.253B for Dec. 31, 2025
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Glaukos Corp. | 656.16M |
| Edgewise Therapeutics, Inc. | 459.22M |
| Nuvalent, Inc. | 1.070B |
| Marker Therapeutics, Inc. | 18.56M |
| CapsoVision, Inc. | 14.12M |